Pancreatic Cancer Research

ResearcherOgaki Municipal HospitalNo recent work listed

Yuji Kaneoka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6212-463X; OpenAlex author ID A5102020397. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper

Papers 5

  1. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Co-author DOI 10.1111/cas.14258↗
  2. Comparison of end-to-end anastomosis and interposition graft during pancreatoduodenectomy with portal vein reconstruction for pancreatic ductal adenocarcinoma. Last author DOI 10.1007/s00423-019-01749-2↗
  3. Health-related quality of life of adjuvant chemotherapy with S-1 versus gemcitabine for resected pancreatic cancer: Results from a randomised phase III trial (… Co-author DOI 10.1016/j.ejca.2018.01.081↗
  4. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail. First author DOI 10.1016/j.ijsu.2016.09.076↗
  5. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Co-author DOI 10.1016/s0140-6736(16)30583-9↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akira Fukutomi · 3 shared papers, 2016–2020 · strength 0.19
  2. Shoji Nakamori · 3 shared papers, 2016–2020 · strength 0.19
  3. Narikazu Boku · 3 shared papers, 2016–2020 · strength 0.19
  4. Naohiro Sata · 3 shared papers, 2016–2020 · strength 0.19
  5. Katsuhiko Uesaka · 3 shared papers, 2016–2020 · strength 0.19
  6. Yukiyasu Okamura · 3 shared papers, 2016–2020 · strength 0.19
  7. Soichiro Morinaga · 3 shared papers, 2016–2020 · strength 0.19
  8. Satoshi Hirano · 3 shared papers, 2016–2020 · strength 0.19
  9. Yasuyuki Fukami · 2 shared papers, 2016–2019 · strength 0.18
  10. Atsuyuki Maeda · 2 shared papers, 2016–2019 · strength 0.18
  11. Fumihiro Terasaki · 1 shared paper, 2019 · strength 0.11
  12. Takeshi Sudo · 2 shared papers, 2016–2018 · strength 0.11
  13. Koji Imai · 2 shared papers, 2016–2018 · strength 0.11
  14. Yasuo Ohashi · 2 shared papers, 2016–2018 · strength 0.11
  15. Ippei Matsumoto · 2 shared papers, 2016–2018 · strength 0.11
  16. Amane Takahashi · 1 shared paper, 2020 · strength 0.08
  17. Masato Nagino · 1 shared paper, 2020 · strength 0.08
  18. Hiroto Narimatsu · 1 shared paper, 2020 · strength 0.08
  19. Keita P. Mori · 1 shared paper, 2020 · strength 0.08
  20. Hirochika Toyama · 1 shared paper, 2020 · strength 0.08
  21. Akio Yanagisawa · 1 shared paper, 2020 · strength 0.08
  22. Shunsuke Onoe · 1 shared paper, 2016 · strength 0.08
  23. Yasuhiro Hagiwara · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.